Akèy › Kansè (tout kalite) › North Carolina › Durham
Etid klinik pou Kansè (tout kalite) nan Durham, NC
58 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Ap rekriteFaz 1/2
- GSK Investigational Site, Durham
A Study of PHN-012 in Patients With Advanced Solid Tumors
Ap rekriteFaz 1
- PHN-012-001 Site, Durham
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Ap rekriteEtid obsèvasyon
- The University of North Carolina Chapel Hill, Chapel Hill · 10 mi lwen
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Ap rekriteFaz 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 mi lwen
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Ap rekriteFaz 3
- Duke University Medical Center, Durham
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Ap rekriteFaz 3
- Duke University Medical Center - Duke Cancer Centre, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Ap rekriteFaz 3
- Quetzal Site 27, Chapel Hill · 10 mi lwen
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi lwen
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Ap rekriteFaz 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Ap rekriteFaz 2/3
- Duke University Medical Center, Durham
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Digital Art Therapy for Young Cancer Survivors
Ap rekrite
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
Ap rekriteFaz 1
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill · 10 mi lwen
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Ap rekriteFaz 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Ap rekriteFaz 1/2
- University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill · 10 mi lwen
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Ap rekriteFaz 1
- Duke Cancer Institute, Durham
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · 10 mi lwen
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Ap rekriteFaz 3
- Duke Cancer Center, Durham
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
Ap rekrite
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Ap rekriteFaz 3
- University of North Carolina Chapel Hill, Chapel Hill · 10 mi lwen
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Ap rekriteFaz 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Duke University, Durham
Behavioral Pain Intervention for Older Cancer Patients
Ap rekrite
- Duke Cancer Network, Durham
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Ap rekriteFaz 1
- Duke Cancer Institute, Durham
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
Ap rekriteVolontè an sante akeyi
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Ap rekriteFaz 1/2
- University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill · 10 mi lwen
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 1
- University of North Carolina /ID# 251203, Chapel Hill · 10 mi lwen
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Ap rekriteFaz 2
- Duke University Medical Center /ID# 279457, Durham
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Ap rekriteFaz 1
- Duke Cancer Center, Durham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Ap rekrite
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Ap rekriteVolontè an sante akeyi
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10 mi lwen
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Ap rekrite
- Durham VA Medical Center, Durham, NC, Durham
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Ap rekriteEtid obsèvasyon
- University of North Carolina, Chapel Hill · 10 mi lwen
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Ap rekriteFaz 1
- Research Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Ap rekriteFaz 1
- Duke Cancer Center /ID# 251975, Durham
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Ap rekriteFaz 2
- Duke Comprehensive Cancer Center, Durham
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
Ap rekrite
- Durham VA Medical Center, Durham, NC, Durham
Improving Outcomes in Early Menopause After Cancer
Ap rekrite
- Duke Cancer Institute, Durham
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
Ap rekriteEtid obsèvasyon
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors
Ap rekriteVolontè an sante akeyi
- Duke Cancer Institute, Durham
UNC Metastatic Cancer Radiation Therapy Registry
Ap rekriteEtid obsèvasyon
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi lwen
Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors
Ap rekriteEtid obsèvasyon
- UNC Hospitals, Chapel Hill · 10 mi lwen
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Ap rekriteFaz 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Ap rekrite
- Durham VA Medical Center, Durham, NC, Durham
Rehabilitation Outcomes Study
Ap rekrite
- The N.C. Cancer Hospital, Chapel Hill · 10 mi lwen
Cancer and Mild Cognitive Impairment Dyadic Intervention
Ap rekrite
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Ap rekriteFaz 2
- University of North Carolina /ID# 233313, Chapel Hill · 10 mi lwen
GEMINI-NSCLC: NSCLC Biomarker Study
Ap rekriteEtid obsèvasyon
- Duke University, Durham
- UNC, Chapel Hill · 10 mi lwen
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Ap rekrite
- Duke Cancer Institute, Durham
Effectiveness of Central Oncology Navigation and the Use of an ORN
Ap rekrite
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)
Ap rekrite
- Duke University School of Medicine, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi lwen
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Ap rekriteEtid obsèvasyon
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi lwen
Young Adult Infusion Space Experience Satisfaction Survey
Ap rekriteEtid obsèvasyon
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
UNC Pleural Fluid Registry
Ap rekriteEtid obsèvasyon
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
A Study of NX-1607 in Adults With Advanced Malignancies
Ap rekriteFaz 1
- University of North Carolina, Chapel Hill · 10 mi lwen
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Ap rekrite
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · 13 mi lwen
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY109 etid
- Boston, MA85 etid
- Los Angeles, CA74 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Washington, DC58 etid
- Chicago, IL51 etid
- Atlanta, GA49 etid
- Seattle, WA49 etid
- Arlington, VA48 etid
- St. Louis, MO46 etid
Lòt etid nan Durham
- Kansè nan tete64 etid
- Kansè Poumon ki pa ti selil39 etid
- Myelom Miltip37 etid
- Leksemi mieloïd egi33 etid
- Kansè Metastatik33 etid
- Kansè pwostat32 etid
- Kansè poumon32 etid
- Kansè kolorektal28 etid
- Kansè ovè27 etid
- Lukemi lenfositè kwonik27 etid
- Ensifizyans kadyak26 etid
- Kansè pankreyas24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.